Bonfante V - Search Results

1

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

Bonadonna G, Santoro A, Gianni AM, Viviani S, Siena S, Bregni M, Zucali R, Lombardi F, Bonfante V, Gianni L, et al. Bonadonna G, et al. Among authors: bonfante v. Ann Oncol. 1991 Jan;2 Suppl 1:9-16. doi: 10.1093/annonc/2.suppl_1.9. Ann Oncol. 1991. PMID: 1710489 Free article. Review.

2

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

Bonadonna G, Bonfante V, Viviani S, Di Russo A, Villani F, Valagussa P. Bonadonna G, et al. Among authors: bonfante v. J Clin Oncol. 2004 Jul 15;22(14):2835-41. doi: 10.1200/JCO.2004.12.170. Epub 2004 Jun 15. J Clin Oncol. 2004. PMID: 15199092 Clinical Trial.

3

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.

Bonadonna G, Viviani S, Bonfante V, Gianni AM, Valagussa P. Bonadonna G, et al. Among authors: bonfante v. Eur J Cancer. 2005 May;41(7):998-1006. doi: 10.1016/j.ejca.2005.01.006. Epub 2005 Feb 24. Eur J Cancer. 2005. PMID: 15862748

4

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Viviani S, Zinzani PL, Rambaldi A, Brusamolino E, Levis A, Bonfante V, Vitolo U, Pulsoni A, Liberati AM, Specchia G, Valagussa P, Rossi A, Zaja F, Pogliani EM, Pregno P, Gotti M, Gallamini A, Rota Scalabrini D, Bonadonna G, Gianni AM; Michelangelo Foundation; Gruppo Italiano di Terapie Innovative nei Linfomi; Intergruppo Italiano Linfomi. Viviani S, et al. Among authors: bonfante v. N Engl J Med. 2011 Jul 21;365(3):203-12. doi: 10.1056/NEJMoa1100340. N Engl J Med. 2011. PMID: 21774708 Free article. Clinical Trial.

5

ABVD in the treatment of Hodgkin's disease.

Bonfante V, Santoro A, Viviani S, Valagussa P, Bonadonna G. Bonfante V, et al. Semin Oncol. 1992 Apr;19(2 Suppl 5):38-44; discussion 44-5. Semin Oncol. 1992. PMID: 1384143 Review.

6

Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.

Bonfante V, Santoro A, Viviani S, Zucali R, Devizzi L, Zanini M, Tesoro Tess JD, Valagussa P, Banfi A, Bonadonna G. Bonfante V, et al. Eur J Cancer. 1992;29A(1):24-9. doi: 10.1016/0959-8049(93)90570-6. Eur J Cancer. 1992. PMID: 1445741

7

Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.

Viviani S, Santoro A, Negretti E, Bonfante V, Valagussa P, Bonadonna G. Viviani S, et al. Among authors: bonfante v. Ann Oncol. 1990;1(2):123-7. doi: 10.1093/oxfordjournals.annonc.a057689. Ann Oncol. 1990. PMID: 1706614 Free article.

8

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.

Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Viviani S, et al. Among authors: bonfante v. Eur J Cancer Clin Oncol. 1985 May;21(5):601-5. doi: 10.1016/0277-5379(85)90088-4. Eur J Cancer Clin Oncol. 1985. PMID: 2408897 Clinical Trial.

9

CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.

Santoro A, Viviani S, Valagussa P, Bonfante V, Bonadonna G. Santoro A, et al. Among authors: bonfante v. Semin Oncol. 1986 Mar;13(1 Suppl 1):23-6. Semin Oncol. 1986. PMID: 2420012

10

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, Pagnoni AM, Bonfante V, Musumeci R, Crippa F, et al. Santoro A, et al. Among authors: bonfante v. J Clin Oncol. 1987 Jan;5(1):27-37. doi: 10.1200/JCO.1987.5.1.27. J Clin Oncol. 1987. PMID: 2433409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page